Medical devices, healthcare technology and the business of care
PMA approval · P120020

SUPERA PERIPHERAL STENT SYSTEM

Abbott Vascular (Idef Technologies Inc) · Decision date Mar 28, 2014

FDA DECISIONP120020

What did the FDA approve?

FDA records P120020 as an original PMA application. The recorded decision is approval, dated Mar 28, 2014.

FDA approval order statement

APPROVAL FOR THE SUPERA PERIPHERAL STENT SYSTEM. THIS DEVICE IS INDICATED TO IMPROVE LUMINAL DIAMETER IN THE TREATMENT OF PATIENTS WITH SYMPTOMATIC DE NOVO OR RESTENOTIC NATIVE LESIONS OR OCCLUSIONS OF THE SUPERFICIAL FEMORAL ARTERY (SFA) AND/OR PROXIMAL POPLITEAL ARTERY, WITH REFERENCE VESSEL DIAMETERS OF 4.0 TO 6.5 MM, AND LESION LENGTHS UP TO 140 MM.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Mar 28, 2014

FDA source record

Regulatory record facts

Identifier
P120020
Regulatory pathway
Premarket approval application
Product code
NIP
Decision code
APPR
Decision date
Mar 28, 2014
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, SUPERFICIAL FEMORAL ARTERY.

Product code
NIP
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P120020 received

    Application receipt date recorded by FDA.

  2. P120020 · FDA decision

    APPR

  3. P120020/S037 · Related supplement

    Supera Peripheral Stent System

Timeline entries are records held by MedtechLedger for P120020. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P120020

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Vascular (Idef Technologies Inc)PMA supplementNov 6, 2026FDA

Explore the linked device profile

Other records with product code NIP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Vascular (Idef Technologies Inc)

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3200 Lakeside Dr., Santa Clara, CA, 95054

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records